RBC Bioscience Corporation (TPEX: 6848)
Health Care · Life Sciences Tools & Services · TW
NT$21.40
-0.23% today · +18.2% 1Y
RBC Bioscience Corporation (TPEX: 6848) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $9.55M and employs 50 people.
Over the last twelve months the share price has gained 18.2%, trading between 14.30 and 28.15.
Tweenvest scores RBC Bioscience Corporation across four factors: quality 55/100, value 47/100, growth 64/100, dividend 100/100. Its strongest factor is dividend.
6848 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.55M
- Revenue (TTM)
- $6.93M
- P/E
- 14.55
- EPS
- 1.47
- Dividend yield
- 16.52%
- Beta (5Y)
- 0.47
- 52-week high
- NT$28.15
- 52-week low
- NT$14.30
- Avg volume (3M)
- —
- Shares outstanding
- 14.27M
- Employees
- 50
- Next earnings
- —
About RBC Bioscience Corporation
RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
- ISIN
- TW0006848005
- Founded
- 1995
- Listed since
- Oct 25, 2021
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Welgene Biotech Co.,Ltd.TPEX: 6661 | $12.58M | NT$17.20 | +6.17% |
| Pharma-Bio Serv, Inc.OTCPK: PBSV | $10.99M | $0.48 | -4.00% |
| Memphasys LimitedASX: MEM | $10.77M | AU$0.01 | -16.67% |
| China Health Group Inc.SEHK: 8225 | $10.02M | HK$0.08 | +12.86% |
| IDL Diagnostics AB (publ)OM: IDLDX | $8.89M | Skr0.39 | +4.32% |
| PhoenixBio Co., Ltd.TSE: 6190 | $8.17M | ¥318.00 | +1.27% |
| BioLight Life Sciences Ltd.TASE: BOLT | $7.99M | ₪2.70 | -7.10% |
| Medicofarma Biotech SAWSE: MDB | $6.52M | zł0.38 | -3.59% |
Figures last refreshed Oct 11, 2026.